Clinical Trial Update: LMB-7 Immunotoxin in Treating Patients With Leptomeningeal Metastases [Phase 1]

View source ↗

Summary

Phase 1 clinical trial of LMB-7 Immunotoxin for leptomeningeal metastasis has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Leptomeningeal Metastasis

Drugs mentioned

• LMB-7 Immunotoxin

Snippet

Sponsor: Duke University | Conditions: Brain and Central Nervous System Tumors | Phase 1 | Status: COMPLETED